Top Vaccines companies in Switzerland by EBIT
Switzerland
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 332.00 M
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
| 2 |
USD 25.66 M
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
|
| 3 |
USD -54.12 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
| 4 |
USD -58.08 M
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
| 5 |
USD -64.19 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
| 6 |
USD -73.56 M
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
|
| 7 |
USD -150.03 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
Frequently Asked Questions
-
Which Vaccines company in Switzerland has the highest EBIT ?
The Vaccines company in Switzerland with the highest EBIT is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at USD 332.00 M.
-
Which Vaccines company in Switzerland has the lowest EBIT ?
The Vaccines company in Switzerland with the lowest EBIT is ADC Therapeutics SA (NYSE: ADCT) at USD -150.03 M.
-
What are the top 10 Vaccines companies in Switzerland by EBIT ?
The top 10 Vaccines companies in Switzerland by EBIT are Sandoz Group AG, Basilea Pharmaceutica AG, MoonLake Immunotherapeutics, PolyPeptide Group AG, AC Immune SA, Molecular Partners AG and ADC Therapeutics SA.
-
What are the bottom 10 Vaccines companies in Switzerland by EBIT ?
The bottom 10 Vaccines companies in Switzerland by EBIT are ADC Therapeutics SA, Molecular Partners AG, AC Immune SA, PolyPeptide Group AG, MoonLake Immunotherapeutics, Basilea Pharmaceutica AG and Sandoz Group AG.
